Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
Julien Carvelli, Olivier Demaria, Fréderic Vely, et al.
Nature (2020) Vol. 588, Iss. 7836, pp. 146-150
Open Access | Times Cited: 475

Showing 1-25 of 475 citing articles:

Genetic mechanisms of critical illness in COVID-19
Erola Pairo‐Castineira, Sara Clohisey, Lucija Klarić, et al.
Nature (2020) Vol. 591, Iss. 7848, pp. 92-98
Open Access | Times Cited: 1366
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski, Martin Sebastian Winkler, Tomasz Skirecki, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 622-642
Open Access | Times Cited: 479
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 420
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan Cato Holter, Søren Erik Pischke, Eline de Boer, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 40, pp. 25018-25025
Open Access | Times Cited: 377
Inflammasome activation at the crux of severe COVID-19
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 292
Ventilator-associated pneumonia in critically ill patients with COVID-19
Mailis Maes, Ellen E. Higginson, Joana Pereira-Dias, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 286
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 475-495
Open Access | Times Cited: 254
Neutrophils in COVID-19
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 251
Microthrombi as a Major Cause of Cardiac Injury in COVID-19
Dario Pellegrini, Rika Kawakami, Giulio Guagliumi, et al.
Circulation (2021) Vol. 143, Iss. 10, pp. 1031-1042
Open Access | Times Cited: 238
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, et al.
Clinical Immunology (2020) Vol. 220, pp. 108598-108598
Open Access | Times Cited: 235
The state of complement in COVID-19
Behdad Afzali, Marina Noris, Bart N. Lambrecht, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 2, pp. 77-84
Open Access | Times Cited: 231
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins, et al.
Science Immunology (2021) Vol. 6, Iss. 57
Open Access | Times Cited: 215
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
Christopher T. Rentsch, Joshua A. Beckman, Laurie A. Tomlinson, et al.
BMJ (2021), pp. n311-n311
Open Access | Times Cited: 212
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 205
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
Lina Ma, Sanjaya Kumar Sahu, Marlene Cano, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 198
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 12, pp. e764-e773
Open Access | Times Cited: 187
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 493-512.e25
Open Access | Times Cited: 187
Does tissue imprinting restrict macrophage plasticity?
Martin Guilliams, Freya R. Svedberg
Nature Immunology (2021) Vol. 22, Iss. 2, pp. 118-127
Open Access | Times Cited: 170
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
Bingyu Yan, Tilo Freiwald, Daniel Chauss, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 169
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
Djillali Annane, Nicholas Heming, Lamiae Grimaldi‐Bensouda, et al.
EClinicalMedicine (2020) Vol. 28, pp. 100590-100590
Open Access | Times Cited: 159
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
Daniel Chauss, Tilo Freiwald, Reuben McGregor, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 62-74
Open Access | Times Cited: 159
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
Journal of Autoimmunity (2020) Vol. 116, pp. 102560-102560
Open Access | Times Cited: 152
Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 12, pp. 2042-2057
Open Access | Times Cited: 146
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner, Tom Eirik Mollnes
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 792-827
Open Access | Times Cited: 137
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
Matteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 275-286
Open Access | Times Cited: 137
Page 1 - Next Page

Scroll to top